Dominic Culligan

Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

John Radford, Tim Illidge, Nicholas Counsell et al. · New England Journal of Medicine · 2015 · 750 citations · Full text

Medicine, Oncology, Radiology +16

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

Neil A. Marshall, Linsey Christie, Laura Munro et al. · Blood · 2003 · 512 citations · Full text

Life Sciences, Immunology, Oncology +13

Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes

David Bowen, Dominic Culligan, Simon N. Jowitt et al. · British Journal of Haematology · 2003 · 297 citations

Medicine, Hematology, Internal Medicine +15

Inferior vena cava malformation as a risk factor for deep venous thrombosis in the young

Yen‐Lin Chee, Dominic Culligan, Henry G. Watson · British Journal of Haematology · 2001 · 230 citations · Full text

Medicine, Hematology, Surgery +12

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 159 citations · Full text

Medicine, Immunology, Oncology +13